Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boston top stories
cancer immunotherapy
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
eli lilly
fda
investing
medicare
bristol-myers squibb
celgene
johnson & johnson
merck
nivolumab
What
companies
6
×
bio
roundup
drug
ipo
life
new
science
week
latest
momentum
nash
news
price
raised
alzheimer’s
approval
approved
arena’s
arrival
biogen’s
biopharmaceutical
biotech
biotechs
bounty
cig
club
comeback
continued
convo
corner
crop
days
deals
delivered
different
digital
disease
earlier
epidemic
Language
unset
Current search:
biotech
×
companies
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M